FILED AND SPONSOR-REPORTED ETF HOLDINGS
LXEO Included in ETFs
Dates are first observed in retained official snapshots; “baseline” means the security was already present in the earliest retained snapshot and is not an invented original addition date.
Current ETFs holding LXEO
5 latest ETF portfolios currently report this security.
| ETF | Fund | Weight | Added / first observed | Latest report |
|---|---|---|---|---|
| BBC | Virtus Biotech Clinical Trials Etf | 0.43091% | 2026-01-30 (baseline) | 2026-04-30 |
| LABU | Direxion Daily S&P Biotech Bull 3X Shares | 0.119187% | 2026-04-30 (baseline) | 2026-04-30 |
| RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.035529% | 2026-01-31 (baseline) | 2026-04-30 |
| ISCB | iShares Morningstar Small-Cap ETF | 0.005278% | 2026-01-31 (baseline) | 2026-04-30 |
| IWV | iShares Russell 3000 ETF | 0.000646% | 2025-12-31 (baseline) | 2026-03-31 |
Previous ETFs holding LXEO
| ETF | Fund | Added / first observed | Removed / first absent |
|---|---|---|---|
| FSML | Franklin Small Cap Enhanced ETF | 2025-12-31 (baseline) | 2026-03-31 |